Učitavanje...
DHCR24 predicts poor clinicopathological features of patients with bladder cancer: A STROBE-compliant study
To investigate the prognostic value of DHCR24 for patients with bladder cancer (BC). We used public bladder cancer microarray studies to evaluate the expression of DHCR24 between normal bladder tissues and BC cells, to investigate the relationship between the expression of DHCR24 and the clinical fe...
Spremljeno u:
| Izdano u: | Medicine (Baltimore) |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wolters Kluwer Health
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6181456/ https://ncbi.nlm.nih.gov/pubmed/30278482 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000011830 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|